Hikal Limited (HIKAL.NS)
- Previous Close
402.65 - Open
402.55 - Bid --
- Ask --
- Day's Range
399.80 - 412.25 - 52 Week Range
267.25 - 464.75 - Volume
250,242 - Avg. Volume
406,279 - Market Cap (intraday)
49.888B - Beta (5Y Monthly) 0.66
- PE Ratio (TTM)
54.90 - EPS (TTM)
7.37 - Earnings Date Jul 30, 2025 - Aug 4, 2025
- Forward Dividend & Yield 1.20 (0.30%)
- Ex-Dividend Date Feb 7, 2025
- 1y Target Est
540.00
Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal health, biotech, crop protection, and specialty chemicals companies in India, the United States, Canada, Europe, South East Asia, and internationally. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredients (APIs). Its Crop Protection segment manufactures pesticides and herbicides, which include diuron tech, temephos tech, thiacloprid tech, clothianidin tech, dichloroaniline, N-bromosuccinimide, prothioconazole technical, trifloxystrobin technical, and BIT. The company also collaborates with other companies; and offers solutions in contract research, custom synthesis, and custom manufacturing of intermediates and active ingredients. In addition, it offers human health products, such as anti-convulsant, anti-emetic, anti-histaminic, anti-depressant, anti-psychotic, anti-lipemic, hemorheologic, anti-diabetic, anti-thrombotic, anti-hypertensive, anti-inflammation, and analgesic; animal health products, such as anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone, and NSAID; and specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company also exports its products. The company was formerly known as Hikal Chemical Industries Ltd. and changed its name to Hikal Limited in April 2000. Hikal Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.
www.hikal.com--
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: HIKAL.NS
View MorePerformance Overview: HIKAL.NS
Trailing total returns as of 5/21/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HIKAL.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HIKAL.NS
View MoreValuation Measures
Market Cap
49.62B
Enterprise Value
56.43B
Trailing P/E
54.71
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.69
Price/Book (mrq)
3.93
Enterprise Value/Revenue
3.06
Enterprise Value/EBITDA
16.93
Financial Highlights
Profitability and Income Statement
Profit Margin
4.88%
Return on Assets (ttm)
4.96%
Return on Equity (ttm)
7.41%
Revenue (ttm)
18.6B
Net Income Avi to Common (ttm)
908M
Diluted EPS (ttm)
7.37
Balance Sheet and Cash Flow
Total Cash (mrq)
180M
Total Debt/Equity (mrq)
60.58%
Levered Free Cash Flow (ttm)
808.52M